Literature DB >> 19901136

Fifty years of thiazide diuretic therapy for hypertension.

Marvin Moser1, Peter U Feig.   

Abstract

BACKGROUND: The use of thiazide diuretics has decreased over the past 30 years despite data from many well-controlled clinical trials demonstrating that the use of these agents as monotherapy or in combination with other antihypertensive agents will reduce blood pressure and decrease cardiovascular as well as cerebrovascular events.
METHODS: We reviewed clinical and experimental data on thiazide diuretics since their introduction in the late 1950s.
RESULTS: The results of thiazide-based therapy in young and old are consistently positive despite concerns about some metabolic changes, eg, insulin resistance or hypokalemia, that may occur.
CONCLUSION: We conclude that these agents are safe, effective, and well tolerated and should continue to be used either as monotherapy or with other medications in the management of hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901136     DOI: 10.1001/archinternmed.2009.342

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial.

Authors:  Shanthi Mendis; S Claiborne Johnston; Wu Fan; Olulola Oladapo; Ali Cameron; Mohammed F Faramawi
Journal:  Bull World Health Organ       Date:  2009-12-08       Impact factor: 9.408

Review 2.  The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation.

Authors:  Arthur D Moes; Nils van der Lubbe; Robert Zietse; Johannes Loffing; Ewout J Hoorn
Journal:  Pflugers Arch       Date:  2013-12-06       Impact factor: 3.657

3.  Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.

Authors:  X Xiao; Y Xu; Q Wu
Journal:  Osteoporos Int       Date:  2018-03-25       Impact factor: 4.507

4.  Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.

Authors:  Peter Bramlage; Hartmut Buhck; Claudia Zemmrich
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

5.  Thienoquinolins exert diuresis by strongly inhibiting UT-A urea transporters.

Authors:  Huiwen Ren; Yanhua Wang; Yongning Xing; Jianhua Ran; Ming Liu; Tianluo Lei; Hong Zhou; Runtao Li; Jeff M Sands; Baoxue Yang
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-08

6.  Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension.

Authors:  Wanzhu Tu; Brian S Decker; Zangdong He; Blake L Erdel; George J Eckert; Richard N Hellman; Michael D Murray; John A Oates; J Howard Pratt
Journal:  J Gen Intern Med       Date:  2016-01       Impact factor: 5.128

Review 7.  The Story of the Silent Killer : A History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debates.

Authors:  Jonathan P Kalehoff; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2020-08-27       Impact factor: 5.369

Review 8.  Treatment of hypertension in older persons: what is the evidence?

Authors:  John E Morley
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

Review 9.  Hypertension: a new treatment for an old disease? Targeting the immune system.

Authors:  Gisele Facholi Bomfim; Stefany Bruno Assis Cau; Alexandre Santos Bruno; Aline Garcia Fedoce; Fernando S Carneiro
Journal:  Br J Pharmacol       Date:  2018-07-31       Impact factor: 8.739

10.  Powerful diuretics: A common denominator in landmark hypertension and type 2 diabetes mellitus trials.

Authors:  Kaberi Dasgupta; Ruth Sapir-Pichhadze; Nadia Khan
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.